(Q33491476)

27 July 2017

title

Enzyme replacement treatment in type 1 and type 3 Gaucher's disease (English)

1 reference

27 July 2017

1 reference

B Bembi

1

1 reference

27 July 2017

M Zanatta

2

1 reference

27 July 2017

M Carrozzi

3

1 reference

27 July 2017

F Baralle

4

1 reference

27 July 2017

R Gornati

5

1 reference

27 July 2017

B Berra

6

1 reference

27 July 2017

E Agosti

7

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 December 1994

1 reference

27 July 2017

1 reference

27 July 2017

volume

344

1 reference

27 July 2017

issue

8938

1 reference

27 July 2017

page(s)

1679-1682

1 reference

The varied clinical and laboratory manifestations of type II Gaucher's disease

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Type 2 and type 3 Gaucher disease: a morphological and biochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Structural analysis of the human glucocerebrosidase genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

The human glucocerebrosidase gene and pseudogene: structure and evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Gaucher disease: new molecular approaches to diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Prediction of severity of Gaucher's disease by identification of mutations at DNA level

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

The role of neurogenetics in Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Alglucerase. A review of its therapeutic use in Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Enzyme Augmentation in Moderate to Life-Threatening Gaucher Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

1448C mutation linked to the Pv1.1- genotype in Italian patients with Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Aminohydroxypropylidene-biphosphonate in the treatment of bone lesions in a case of Gaucher's disease type 3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

A less costly regimen of alglucerase to treat Gaucher's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

Treatment of Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990462-6

7 January 2021

10.1016/S0140-6736(94)90462-6

Identifiers

DOI

1 reference

27 July 2017

1 reference